ARICEPT better tolerated than Exelon in patients with mild to moderate Alzheimers disease

>Three times as many patients in the Exelon-treatment group reported vomiting compared with the ARICEPT-treatment group (23.6% vs 7.1%).
  • Twice as many patients in the Exelon-treatment group discontinued treatment due to side effects compared with the ARICEPT-treatment group (21.8% vs 10.7%).
  • Almost twice as many patients were able to remain at the maximum daily dose of ARICEPT, 10 mg once a day, than the maximum daily dose of Exelon, 12 mg daily (6 mg twice a day) (87.5% vs 47.3%).
  • Physicians were surveyed about their overall satisfaction with study medication for each patient. Physicians reported being "very satisfied" with study medication for twice as many ARICEPT- as Exelon (rivastigmine tartrate)-treated patients (46.4% of ARICEPT-treated patients; 18.9% of Exelon-treated patients).

    During the 12-week, open-label trial, 111 patients (59% female) with an average age of 74.5 years (51-90 years) were randomized and treated with either ARICEPT or Exelon for 12 weeks. Patients were dosed according to the approved product labeling for each medication.

    Patients in the ARICEPT study arm received 5 mg once daily for 4 weeks and 10 mg once daily thereafter, if tolerated. Patients in the Exelon study arm received 1.5 mg twice daily for 2 weeks with dose increases of 1.5 mg twice daily every 2 weeks until reaching 12 mg (6 mg twice daily), if tolerated. Patients who could not tolerate higher doses were allowed to continue in the study at the next lower tolerated dose. Patients who could not tolerate at least 5 mg daily of ARICEPT (donepezil hydrochloride) or 6 mg daily (3 mg twice daily) of Exelon (rivastigmine tartrate) were discontinued from the study.

    In this study, the most frequent treatment-emergent adverse events for ARICEPT versus Exelon included: nausea (10.7% vs 41.8%); vomiting (7.1% vs 23.6%); headache (7.1% vs 18.2%); anorexia (1.8% vs 9.1%); abnormal dreams (7.1% vs 1.8%); back pain (7.1% vs 0.0%); som

  • Contact: Celeste Torello, Pfizer Inc.
    Porter Novelli

    Page: 1 2 3 4

    Related medicine news :

    1. ARICEPT significantly improves cognition, daily living over Reminyl in Alzheimers patients
    2. First-of-its-kind study of vascular dementia patients taking ARICEPT presented at AAGP meeting
    3. Vascular dementia patients taking ARICEPT show significant treatment benefits in cognition and function
    4. Do minorities survive hospitalization better than others?
    5. Boston University team finds link between high cholesterol and better cognitive performance
    6. Specialist care gives better rate of survival
    7. Balance and better interactions between primary-care and specialist physicians improve US health
    8. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines
    9. Pet scanning better for heart disease diagnosis, management
    10. Laughter helps blood vessels function better
    11. MRI better than current standard in assessing neoadjuvant chemotherapy for breast cancer

    Post Your Comments:

    (Date:3/28/2020)... MYRTLE BEACH, S.C. (PRWEB) , ... March 27, ... ... regionally renowned orthopedic practice OrthoSC is now offering telemedicine as an ... visit with one of the practice’s doctors in the comfort of their own ...
    (Date:3/27/2020)... (PRWEB) , ... March 27, 2020 , ... ... reviewed and approved by NJ Top Docs. Dr. Kubeck has been approved every ... of Orthopaedic Surgery and specializes in Spinal Surgery. , Dr. Kubeck’s medical ...
    (Date:3/22/2020)... ... March 21, 2020 , ... ... and the Modular Home Builders Association (MHBA), have been working with state and ... MHBA has been advocating for greater use of modular construction to address the ...
    (Date:3/22/2020)... (PRWEB) , ... March 22, 2020 , ... ... self-awareness and mindfulness may appear to be a frivolous luxury. The world’s focus ... and trying to find some sense of stability and control in chaos. However, ...
    (Date:3/20/2020)... , ... March 21, 2020 , ... ... and legal communities together for a day of live discussion and learning online. ... advocacy and ethics, telemedicine, whistleblower laws, the role of boards, fraud, waste and ...
    Breaking Medicine News(10 mins):
    (Date:4/1/2020)... ... April 01, 2020 , ... ... continuing her partnership with the esteemed Haute Beauty network. , The Haute Beauty ... Dr. Green as a leading Anti-Aging Expert. , Haute Beauty offers a prominent ...
    (Date:4/1/2020)... ... April 01, 2020 , ... ... producing reusable face shields. As large manufacturers nation-wide scramble to retool their machinery ... reusing masks or in extreme cases, using hand-sewn masks to protect employees from ...
    (Date:3/30/2020)... (PRWEB) , ... March 30, 2020 , ... ... announced it has been recognized by Dresner Advisory Services as the #2 vendor ... its capabilities related to data orchestration, data transformation, and data integration for a ...
    Breaking Medicine Technology:
    Cached News: